1.Comparison among measures to prevent intrauterine adhesions after artificial abortion.
Lei LI ; Manman NAI ; Guixiang GAO ; Luwen WANG
Journal of Central South University(Medical Sciences) 2016;41(9):975-978
OBJECTIVE:
To investigate the clinical efficacy of oral medicine and sodium hyaluronate in prevention of intrauterine adhesions after artificial abortion.
METHODS:
A total of 572 patients with early pregnancy termination through artificial abortion, who experienced two or more times of abortion, were retrospectively analyzed. Patients were randomly and voluntarily divided into 4 groups: an artificial cycle group, a drospirenone and ethinylestradiol tablets group, a sodium hyaluronate group, and a control group. The thickness of the endometrium, return time of menses, and the status of intrauterine adhesions were observed.
RESULTS:
The thickness of the endometrium in the artificial period group was greater than that in the control group (P<0.001). It was less in the drospirenone and ethinylestradiol tablets group comparing with that in the control group (P<0.001). There was no significant difference in the thickness of the endometrium between the sodium hyaluronate group and the control group (P=0.717). Return time of menses in the artificial menstrual cycle group and the drospirenone and ethinylestradiol tablets group was shorter than that in the control group (P<0.001). There was no significant difference in return time of menses between the sodium hyaluronate group and the control group (P=0.813). The incidence of intrauterine adhesions could be reduced by the 3 preventive measures (All P<0.01).
CONCLUSION
Drugs for artificial cycle and drospirenone and ethinylestradiol tablets medication immediately after artificial abortion can effectively promote endometrial repair and reduce the incidence of intrauterine adhesions. However, for the patients with poor compliance, drospirenoneand ethinylestradiol tablets are the first choice for prevention of intrauterine adhesion.
Abortion, Induced
;
adverse effects
;
Androstenes
;
pharmacology
;
therapeutic use
;
Endometrium
;
anatomy & histology
;
drug effects
;
Ethinyl Estradiol
;
pharmacology
;
therapeutic use
;
Female
;
Humans
;
Hyaluronic Acid
;
pharmacology
;
therapeutic use
;
Menstrual Cycle
;
drug effects
;
Menstruation
;
drug effects
;
Pregnancy
;
Tissue Adhesions
;
etiology
;
prevention & control
2.Mining analysis on composition and medication of menstruation prescriptions in Fu Qingzhu's Obstetrics and Gynecology.
China Journal of Chinese Materia Medica 2015;40(8):1610-1613
In this paper, menstruation prescriptions were selected from "Fu Qingzhu's Obstetrics and Gynecology" and analyzed by using GRI algorithm, correlation analysis, hierarchical clustering method through SPSS, Clementine and traditional Chinese medicine (TCM) inheritance auxiliary systems, in order to screen out 15 menopathy prescriptions, which involve 45 traditional Chinese medicine herbs. In the study, blood-tonifying and qi-tonifying herbs were found to be frequent in the prescriptions. The most frequent single herb was white paeony root, accounting for 9.6% in the total number of prescriptions; The most frequent herb pairs were white paeony root-radix rehmanniae preparata and paeony root-angelica sinensis. Among Fu Shan's menopathy prescriptions, 61 herbal pairs showed a correlation coefficient exceeding 0.05, which evolved into 16 pairs of core combinations. The analysis showed that menopathy prescriptions in volume 1 of "Fu Qingzhu's Obstetrics and Gynecology" focused on tonic traditional Chinese medicines involving liver, spleen and kidney and were adjusted according to changes in qi, blood, cold, hot and wet, which could provide a specific reference for further studies on Fu Shan's academic thoughts and traditional Chinese medicine clinical treatment of menopathy.
Books
;
history
;
China
;
Drug Prescriptions
;
history
;
Drug Therapy
;
history
;
Drugs, Chinese Herbal
;
chemistry
;
therapeutic use
;
Female
;
Gynecology
;
History, Ancient
;
Humans
;
Medicine in Literature
;
Menstruation
;
drug effects
3.Systematic evaluation of clinical application of Dingkun Dan.
China Journal of Chinese Materia Medica 2015;40(20):3916-3919
Dingkun Dan is a representative of the classic gynecological medicine. With Tonifying the liver and kidney, supplementing Qi and nourishing blood, regulating menstruation Shuyu, promoting the role of pain. Used in treatment of liver and kidney deficiency, deficiency of both qi and blood, Qi stagnation and blood stasis caused by irregular menstruation, menstrual pain, uterine bleeding, leukorrhea with reddish discharge, bruise blood removal, infertility, and various postpartum deficiency and bone steaming hot flashes of gynecological common disease. In recent years, Dingkun Dan's new uses have been reported, the clinical application value is worth further digging. In this paper, clinical application and research progress of Dingkun Dan since the founding of new China were briefly discussed, and summarize for the randomized controlled trials.
China
;
Drugs, Chinese Herbal
;
administration & dosage
;
Female
;
Humans
;
Infertility, Female
;
drug therapy
;
physiopathology
;
Kidney
;
drug effects
;
physiopathology
;
Liver
;
drug effects
;
physiopathology
;
Menstruation
;
drug effects
;
Randomized Controlled Trials as Topic
4.Preventive effect on menstrual migraine treated with subgaleal acupoint injection with metoclopramide.
Lihong WANG ; Yongsheng WU ; Xinjing SU
Chinese Acupuncture & Moxibustion 2015;35(3):243-246
OBJECTIVETo observe the differences in clinical effect on menstrual migraine between subgaleal acupoint injection with metoclopramide and oral administration of medication.
METHODSSixty-four patients of menstrual migraine were randomized into a subgaleal acupoint injection group and a medication group, 32 cases in each one. In the subgaleal acupoint injection group, the acupoint injection started 10 days before menstruation. Eight acupoints on the head were selected and injected alternatively in two groups, once every 2 days, 4 treatments made one session and 3 sessions (3 menstrual cycles) were required. In the medication group, flunarizine was applied with oral administration, 2.5 mg each time, once every night. The duration of treatment was 3 months. The analgesic effect, frequency and time of pain attack were observed in 3 and 6 months after treatment in the two groups.
RESULTSAfter treatment, VAS scores were lower than those before treatment in the two groups (P<0.01, P<0.05), the attack frequency and pain time were all reduced as compared with those before treatment (all P<0.01). After treatment, VAS score, the frequency and time of pain attack in the subgaleal acupoint injection group were improved significantly as compared with the medication group (all P<0.01).
CONCLUSIONThe subgaleal acupoint injection with metoclopramide achieves the superior preventive effect in clinical treatment of menstrual migraine as compared with flunarizine.
Acupuncture Points ; Adolescent ; Adult ; Female ; Humans ; Menstruation ; drug effects ; Metoclopramide ; administration & dosage ; Migraine Disorders ; drug therapy ; physiopathology ; prevention & control ; Young Adult
5.Clinical effects of shen-nourishing and menstruation-regulating method combined with triptorelin acetate injection on patient with luteinized unruptured follicle syndrome.
Chen YAN-HUA ; Lian FANG ; Na SHI
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(12):1604-1606
OBJECTIVETo study the clinical effects of Shen-nourishing and menstruation-regulating method (SNMRM) combined with Triptorelin Acetate Injection (TAI) on patients with luteinized unruptured follicle syndrome (LUFS).
METHODSSixty-two LUFS patients were randomly assigned to the treatment group and the control group. TAI was given to patients in the control group while SNMRM + TAI was given to those in the treatment group. The ovulation rate and the pregnancy rate were observed in the two groups.
RESULTSThe ovulation rate in the treatment group was higher than that in the control group, but without significant difference (85.53% versus 79.07%, P > 0.05). The pregnancy rate was significantly higher in the treatment group than in the control group (56.25% vs 30.00%, P < 0.05).
CONCLUSIONTreatment of LUFS by SNMRM + TAI could improve the ovulation rate and the pregnancy rate, indicating that LUFS patients' ovary functions could be improved by using different menstruation regulating methods during different follicular development phases.
Adult ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Infertility, Female ; drug therapy ; Menstruation ; drug effects ; Ovarian Diseases ; drug therapy ; Ovarian Follicle ; physiopathology ; Ovulation ; drug effects ; Pregnancy ; Pregnancy Rate ; Triptorelin Pamoate ; therapeutic use ; Young Adult
7.Change of BMD after weaning or resumption of menstruation in Chinese women with different FokI VDR-genotypes: a randomized, placebo-controlled, calcium supplementation trial.
Bo YU ; Hongying WU ; Fang LI ; Jie GONG ; Dunjin ZHOU ; Zhifeng ZHANG ; Xiaoguang YANG ; Zhenwu HUANG
Biomedical and Environmental Sciences 2011;24(3):243-248
OBJECTIVETo investigate the effect of calcium supplementation on bone mineral density (BMD) in Chinese women with different FokI vitamin D receptor (VDR) genotypes (FF, Ff, and ff) after weaning or resumption of menstruation during lactation.
METHODSA total of 40 subjects with the same FokI VDR genotype were randomly divided into two groups: one received calcium tablet (600 mg once daily as CaCO(3)) and the other placebo tablet once daily for 1 year. At baseline, BMD was measured by dual-energy X-ray absorptiometry at lumbar spine (L2-L4) and at left hip whereas serum PICP, serum OC, and urinary CTX, serum 25(OH)VitD(3), and serum estradiol were measured at weaning and 1 year thereafter.
RESULTSAfter the intervention, BMD at lumbar spine and at left hip increased significantly in all these women with a trend among different FokI VDR genotypes such as FF > Ff > ff (P<0.05, <0.01, and <0.001, respectively). BMD at lumbar spine in women with FF VDR genotype increased much more rapidly than in those with ff VDR genotype (P<0.05). Compared with the control group women with the FF genotype regained more BMD after calcium supplementation (P<0.05).
CONCLUSIONDaily calcium 600 mg supplementation has beneficial effect on the bone health of women with FF VDR genotype.
Adult ; Asian Continental Ancestry Group ; Bone Density ; drug effects ; Calcium, Dietary ; administration & dosage ; pharmacology ; Female ; Genotype ; Humans ; Menstruation ; physiology ; Weaning ; Young Adult
8.GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients.
Hyun Jung PARK ; Young Ah KOO ; Young Hyuck IM ; Byung Koo YOON ; DooSeok CHOI
Journal of Korean Medical Science 2010;25(1):110-116
The increased survival of patients with breast cancer has given rise to other problems associated with the complications of chemotherapy. One major complication is premature ovarian failure, an especially harmful outcome for women of reproductive age. This study was performed to evaluate the efficacy of GnRH agonist (GnRHa) treatment on protecting ovarian function in young breast cancer patients (30.59+/-5.1 yr) receiving chemotherapy after surgery. Twenty-two women were enrolled and given subcutaneous injections of leuprolide acetate (3.75 mg) every 4 weeks during chemotherapy. Follow-up laboratory tests (luteinizing hormone [LH], follicle stimulating hormone [FSH], and estradiol) were performed 1, 3, and 6 months after chemotherapy. Menstruation patterns and clinical symptoms were followed up for a mean duration of 35.6+/-1.7 months. FSH and LH levels were normal in all patients 6 months after completing chemotherapy (8.0+/-5.3, 4.4+/-2.7 mIU/mL, respectively). During follow-up, none of the patients complained of menopausal symptoms and 81.8% experienced recovery of menstruation. This report is the first trial of GnRHa as a treatment modality to protect ovarian function during adjuvant chemotherapy in young Korean breast cancer patients.
Adult
;
Antineoplastic Agents/adverse effects/therapeutic use
;
Antineoplastic Agents, Hormonal/therapeutic use
;
Breast Neoplasms/diagnosis/*drug therapy/surgery
;
Combined Modality Therapy
;
Cyclophosphamide/adverse effects/therapeutic use
;
Doxorubicin/adverse effects/therapeutic use
;
Female
;
Follicle Stimulating Hormone/analysis
;
Gonadotropin-Releasing Hormone/*agonists
;
Humans
;
Leuprolide/administration & dosage
;
Luteinizing Hormone/analysis
;
Menstruation
;
Ovarian Function Tests
;
Primary Ovarian Insufficiency/etiology/*prevention & control
;
Republic of Korea
;
Tamoxifen/therapeutic use
;
Time Factors
9.Current progress of Chinese medicinal treatment of endometriosis.
Han JIANG ; Yan SHEN ; Xiang-Gui WANG
Chinese journal of integrative medicine 2010;16(3):283-288
Endometriosis (EM) is one of the common and frequently encountered gynecological diseases that seriously influences women's health. Its morbidity reaches 10%-15% in women at reproductive ages, and shows an evident rising tendency. In recent years, the Chinese medicine treatment of EM has won favorable therapeutic effects with few adverse reactions. A brief review on this topic has been made through analyzing and summarizing recent pertinent literatures in terms of treatment depending on syndrome differentiation, cycle treatment, external treatment, integrative medicinal treatment, so as to try to know the status quo of Chinese medicine treatment on EM, and to provide some instructive views for clinical treatment and research.
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Endometriosis
;
drug therapy
;
etiology
;
physiopathology
;
Female
;
Humans
;
Integrative Medicine
;
Medicine, Chinese Traditional
;
trends
;
Menstruation
;
drug effects
;
physiology
10.A case of Budd-Chiari syndrome induced by ethinylestradiol and cyproterone acetate.
Jing-cheng HE ; Ping XU ; Liu-bao PENG
Chinese Journal of Hepatology 2009;17(12):954-954
Administration, Oral
;
Adult
;
Biomarkers
;
analysis
;
Budd-Chiari Syndrome
;
chemically induced
;
diagnosis
;
pathology
;
Cyproterone Acetate
;
adverse effects
;
therapeutic use
;
Diagnosis, Differential
;
Ethinyl Estradiol
;
adverse effects
;
therapeutic use
;
Female
;
Humans
;
Liver
;
diagnostic imaging
;
pathology
;
Menstruation Disturbances
;
drug therapy
;
Radiography

Result Analysis
Print
Save
E-mail